Literature DB >> 9049233

The interferon sensitivity determining region: all hepatitis C virus isolates are not the same.

D Herion, J H Hoofnagle.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9049233     DOI： 10.1002/hep.510250346

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  14 in total

1.  Mutations around interferon sensitivity-determining region: a pilot resistance report of hepatitis C virus 1b in a Hong Kong population.

Authors:  Xiao-Ming Zhou; Paul Ks Chan; John S Tam
Journal:  World J Gastroenterol       Date:  2011-12-28       Impact factor: 5.742

Review 2.  Interferon alfacon-1: a review of its pharmacology and therapeutic efficacy in the treatment of chronic hepatitis C.

Authors:  E B Melian; G L Plosker
Journal:  Drugs       Date:  2001       Impact factor: 9.546

3.  Predictive factors for interferon and ribavirin combination therapy in patients with chronic hepatitis C.

Authors:  Joonho Yoon; Jong In Lee; Soon Koo Baik; Kwang Ho Lee; Joon Hyung Sohn; Hyean Woo Lee; Jun Namkung; Sei Jin Chang; Jong Whan Choi; Hyun Won Kim; Byung-Il Yeh
Journal:  World J Gastroenterol       Date:  2007-12-14       Impact factor: 5.742

4.  Sustained virological response in hepatitis C virus type 1b infected patients is predicted by the number of mutations within the NS5A-ISDR: a meta-analysis focused on geographical differences.

Authors:  M Pascu; P Martus; M Höhne; B Wiedenmann; U Hopf; E Schreier; T Berg
Journal:  Gut       Date:  2004-09       Impact factor: 23.059

Review 5.  Nonresponse to treatment for hepatitis C: current management strategies.

Authors:  He-Jun Yuan; William M Lee
Journal:  Drugs       Date:  2008       Impact factor: 9.546

6.  Antiapoptotic and oncogenic potentials of hepatitis C virus are linked to interferon resistance by viral repression of the PKR protein kinase.

Authors:  M Gale; B Kwieciszewski; M Dossett; H Nakao; M G Katze
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

7.  Selection of HCV NS5A quasispecies during IFN therapy in patients with chronic HCV.

Authors:  M Paterson; C Laxton; R D Goldin; A M Ackrill; G R Foster
Journal:  Dig Dis Sci       Date:  2001-07       Impact factor: 3.199

8.  Regulation of mRNA translation and cellular signaling by hepatitis C virus nonstructural protein NS5A.

Authors:  Y He; S L Tan; S U Tareen; S Vijaysri; J O Langland; B L Jacobs; M G Katze
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

9.  Hepatitis C virus nonstructural 5A protein induces interleukin-8, leading to partial inhibition of the interferon-induced antiviral response.

Authors:  S J Polyak; K S Khabar; D M Paschal; H J Ezelle; G Duverlie; G N Barber; D E Levy; N Mukaida; D R Gretch
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

10.  The hepatitis C virus NS5A protein and response to interferon alpha: mutational analyses in patients with chronic HCV genotype 3a infection from India.

Authors:  Ankur Goyal; Wolf P Hofmann; Eva Hermann; Stella Traver; Syed S Hissar; Naveen Arora; Hubert E Blum; Stefan Zeuzem; Christoph Sarrazin; Shiv K Sarin
Journal:  Med Microbiol Immunol       Date:  2006-09-06       Impact factor: 3.402
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.